Cypress Systems is launching a premium line of chelated minerals called TheChelates.
Cypress Systems (Fresno, CA) is launching a premium line of pure, fully-reacted chelated minerals called TheChelates. According to the company, the scientifically tested chelated minerals are as close to nature’s natural food form as possible.
“Created with patented chelated technology, TheChelates are superior to other more problematic chelated minerals because they are not diluted, blended or buffered with inorganic minerals. No inorganic buffers means superior absorption,” explains Cypress Systems CEO Paul Willis, in a press release. “They also do not contain maltodextrin, and will not cause the undesirable side effects typically associated with minerals.”
The minerals available under TheChelates line include:
“Our reputation is at stake. Our customers expect high-quality ingredients that are backed by science. We would not be launching TheChelates unless we were confident that they are the purest and most efficacious minerals available,” Willis continues. “Having premium minerals in the right dose, backed by gold-standard research, can be a distinct competitive advantage. We are providing formulators with endless possibilities instead of the typical limitations associated with chelated minerals.”
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
2 Commerce Drive
Cranbury, NJ 08512